Catalyst Pharmaceutical Partners Aktie
20,18
EUR
-0,18
EUR
-0,88
%
23,95
USD
-0,31
USD
-1,26
%
Werbung
Catalyst Pharmaceutical Partners Aktie Analyse
| 21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
| 30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
| 14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
| 29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |
Werbung
Werbung